Skip to main content
Equibles

STATE STREET CORP

Position in ANIX — Anixa Biosciences Inc

CIK 93751 BOSTON, MA
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$445,312
+$34,989 QoQ
Shares Held
159,040
0.0% QoQ
Ownership
0.467%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 62 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 62% Shared 0% None 38%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. ANIX ranks #303 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in ANIX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $445,312 159,040
2026-03-31 $410,323 159,040
2025-12-31 $496,204 159,040
2025-09-30 $397,650 120,500
2025-06-30 $397,650 120,500
2025-03-31 $344,630 120,500
2024-12-31 $279,560 120,500
2024-09-30 $352,485 111,900
2024-06-30 $247,299 111,900
2024-03-31 $338,520 108,500
2023-12-31 $420,980 108,500
2023-09-30 $333,867 102,100
2023-06-30 $326,720 102,100
2023-03-31 $439,030 102,100
2022-12-31 $433,925 102,100
2022-09-30 $502,332 102,100
2022-06-30 $312,426 102,100
2022-03-31 $279,754 102,100
2021-12-31 $269,934 90,887
2021-09-30 $433,530 90,887
2021-06-30 $90,353 23,287